The combination of mutations represents a significant potential risk to accelerate the waning of natural and vaccine-induced immunity. A booster dose ...
from Google Alert - facebook https://ift.tt/3xpmuQo
via IFTTT
Friday, November 26, 2021
Moderna Announces Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant | Business Wire
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment